Skip to main content
Conference/Symposium

2026 Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium

Sponsored by

This event is over.

Event Details:

Overview

The Stanford Blood and Marrow Transplantation and Cellular Therapy Symposium is a two-day hybrid educational activity designed to address the evolving landscape of hematopoietic cell transplantation (HCT) and cellular therapies. As the number of eligible patients and range of disease indications continue to expand, and as supportive care requirements grow increasingly complex, there is a critical need for ongoing education among healthcare providers who refer, manage, and care for these patients before, during, and after therapy. This symposium will provide a comprehensive review of state-of-the-art transplant and cellular therapy approaches for hematologic malignancies and select non-hematologic diseases. Faculty experts will highlight advances in treatment strategies, emerging research, and best practices in supportive care, equipping participants with the knowledge and tools to optimize patient outcomes across the continuum of care.

Registration

Registration fee includes course materials, certificate of participation, breakfast and lunch.  The symposium is a hybrid activity; you can attend in person or virtually.  Please select the corresponding registration type when registering.

Early Bird Rate
Physicians (in person) - $200 
Physicians (virtual) - $200 
Nurses/Allied Health Professionals (in person) - $150
Nurses/Allied Health Professionals (virtual) - $150
Stanford RN - $50
Industry (in person) - $350
Industry (virtual) - $350

After 04/07/2026
Physicians (in person) - $300 
Physicians (virtual) - $300
Nurses/Allied Health Professionals (in person) - $250 
Nurses/Allied Health Professionals (virtual) - $250
Stanford RN - $50
Industry (in person) - $350
Industry (virtual) - $350

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator.

Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. 

Credits

AMA PRA Category 1 Credits™ (13.00 hours), AAPA Category 1 CME credits (13.00 hours), ABIM MOC Part 2 (13.00 hours), ACPE Contact Hours (13.00 hours), ADA CERP Continuing Education Credits (13.00 hours), ANCC Contact Hours (13.00 hours), CA BRN - California Board of Registered Nurses Contact Hours (13.00 hours), Non-Physician Participation Credit (13.00 hours)

Target Audience
Specialties - Hematology, Oncology
Professions - Advance Practice Nurse (APN), Dietetic Technician Registered (DTR), Fellow/Resident, Non-Physician, Nurse, Pharmacist, Physician, Physician Associate, Registered Dietitian, Registered Nurse (RN), Social Worker
 
Objectives
At the conclusion of this activity, learners should be able to:


1. Explore the current and emerging data on the efficacy and safety of cellular therapy, T cell redirecting therapies like bispecific antibodies, gene therapy , autologous and allogenic stem cell transplant in the treatment of hematologic malignancies including leukemia, lymphoma and myeloma. 
2. Examine the role of cellular therapies in the treatment of solid tumors and non-cancer indications
3. Examine correlates of efficacy and toxicity, including predictors of long-term response and functional cure in hematologic malignancies with cellular therapies, T cell direction therapies (bispecific antibodies) and transplant.

Accreditation

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 

Stanford Medicine designates this Live Activity for a maximum of 13.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Live Activity for a maximum of 13 ANCC contact hours.
  
California Board of Registered Nursing (CA BRN)
Stanford Medicine Provider approved by the California Board of Registered Nursing, Provider Number 17874, for 13 contact hours.

Commission on Dietetic Registration (CDR)
Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU).
If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1CPEU)
RD’s and DTRs are to select activity type 102 in their Activity Log. Sphere and Competency selection is at the learner’s discretion.

California Board of Registered Nursing (CA BRN)
Stanford Medicine Provider approved by the California Board of Registered Nursing, Provider Number 17874, for 13 contact hours.

Accreditation Council of Pharmacy Education (ACPE) 
Stanford Medicine designates this knowledge-based activity for a maximum of 13 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. Pharmacist UAN: JA0000751-0000-26-002-L01-P.

American Academy of PAs (AAPA)
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This live activity is designated for 13 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Internal Medicine MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.